Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

29 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

E2905 Source Document Tracking Coversheet NCT00843882

- 28/7/15 - 1 Formulaire, 1 Groupe Item, 13 Eléments de données, 1 Langue
Groupe Item: ECOG clinical trial administrative data
E2905 Source Document Tracking Coversheet NCT00843882 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0EA9D5AE-D3E2-1B14-E044-0003BA3F9857

E3F05 Source Document Tracking Coversheet Form NCT00978458

- 16/6/15 - 1 Formulaire, 1 Groupe Item, 10 Eléments de données, 1 Langue
Groupe Item: ECOG clinical trial administrative data
E3F05 Source Document Tracking Coversheet Form NCT00978458 Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6C1889F9-CDBB-5474-E040-BB89AD431A23

ECOG-E1505 Source Document Tracking Cover Sheet NCT00324805

- 16/6/15 - 1 Formulaire, 3 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Footer module
ECOG-E1505 Source Document Tracking Cover Sheet NCT00324805 Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=080E4673-1BE3-69B1-E044-0003BA3F9857

E1305 Source Document Tracking Coversheet NCT00588770

- 16/6/15 - 1 Formulaire, 3 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Footer module
E1305 Source Document Tracking Coversheet NCT00588770 Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=19F77651-8901-3675-E044-0003BA3F9857

E1105 Source Document Tracking Coversheet NCT00520975

- 16/6/15 - 1 Formulaire, 3 Groupes Item, 13 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Footer module
E1105 Source Document Tracking Coversheet NCT00520975 First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3DA6A565-A759-403A-E044-0003BA3F9857

ECOG-E2108 Source Document Tracking Coversheet NCT01242800

- 16/6/15 - 1 Formulaire, 3 Groupes Item, 13 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Footer module
ECOG-E2108 Source Document Tracking Coversheet NCT01242800 Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=91E2AAB8-28DA-A87B-E040-BB89AD43631D

E5202 Source Document Tracking Coversheet NCT00217737 - E5202 Source Document Tracking Coversheet NCT00217737

- 16/6/15 - 1 Formulaire, 3 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Footer module
E5202 Source Document Tracking Coversheet NCT00217737 Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=852743C1-364D-5F08-E040-BB89AD431700

E5204 Source Document Tracking Coversheet NCT00303628

- 16/6/15 - 1 Formulaire, 3 Groupes Item, 15 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Footer module
E5204 Source Document Tracking Coversheet NCT00303628 Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=08FD88A5-89D0-5626-E044-0003BA3F9857

E1609 Source Document Tracking Coversheet NCT01274338

- 8/6/15 - 1 Formulaire, 4 Groupes Item, 12 Eléments de données, 2 Langues
Groupes Item: ECOG clinical trial administrative data, On Treatment Reporting Period, OFF TREATMENT, Section II
E1609 Source Document Tracking Coversheet NCT01274338 Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9774BC47-50B5-931D-E040-BB89AD43322B

E1609 Source Document Tracking Coversheet NCT01274338

- 8/6/15 - 1 Formulaire, 5 Groupes Item, 12 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, On Treatment Reporting Period, OFF TREATMENT, Document type
E1609 Source Document Tracking Coversheet NCT01274338 Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9774BC47-50B5-931D-E040-BB89AD43322B

E1208 Source Document Tracking Coversheet NCT01004978

- 8/6/15 - 1 Formulaire, 1 Groupe Item, 12 Eléments de données, 1 Langue
Groupe Item: ECOG clinical trial administrative data
E1208 Source Document Tracking Coversheet NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FDC3F1E-42D2-1043-E040-BB89AD430FD1

Lung Cancer NCT01107626 Flow Sheet - E5508 Source Document Tracking Coversheet Form - 2908022v1.0 - E5508 Source Document Tracking Coversheet Form

- 9/1/15 - 1 Formulaire, 3 Groupes Item, 13 Eléments de données, 1 Langue
Groupes Item: Header Module, Header, Document Information
E5508 Source Document Tracking Coversheet Form Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6D435D37-53F7-AA13-E040-BB89AD43538D

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial